Key Findings Zepbound users noted hypertension concerns: Hypertension appeared more frequently in discussions of this newer tirzepatide brand (0.73% of posts)
In contrast, in the placebo group, scores increased by approximately 3 points
The guidelines state, Anesthesiologists should recognize that these conditions can increase the likelihood of regurgitation and pulmonary aspiration and should modify these guidelines based upon their clinical judgment. A previous version states, The guidelines may not apply to, or may need to be modified for, patients with coexisting diseases or conditions that can affect gastric emptying or fluid volume (e.g., pregnancy, obesity, diabetes, hiatal hernia, gastroesophageal reflux disease, ileus or bowel obstruction, emergency care, or enteral tube feeding) and patients in whom airway management might be difficult. Requiring patients to abstain from food for longer than 8 hours, even if the optimal duration was unknown, would have been the most cautious approach, even if it was unenjoyable for patients
FDA-approved versions come in branded boxes and pens Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, or the newer oral option Foundayo
Based on receptor-mediated targeting, BDPR NSs can effectively cross the BBB, target dopaminergic neurons, specifically clear ROS and reduce iron aggregation in PD lesions, and exhibit good neuroprotective effects in PD cell, nematode, and mouse models (226)
While semaglutide and tirzepatide are the most popular of the GLP-1 drugs at the moment, some other medications in this class include liraglutide and dulaglutide